RYTELO 47 mg/1
imetelstat sodium · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Geron Corporation
Rytelo (imetelstat sodium) is an intravenous injection used to treat certain blood disorders by targeting telomerase, an enzyme involved in cell growth. It is administered as an injection and requires a prescription from a healthcare provider.
Key Facts
- Brand Name
- RYTELO
- Generic Name
- imetelstat sodium
- NDC Code (Product)
82959-112- Manufacturer
- Geron Corporation
- Strength
- 47 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA217779
- Marketing Start
- 06/06/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is RYTELO used for?
Rytelo (imetelstat sodium) is an intravenous injection used to treat certain blood disorders by targeting telomerase, an enzyme involved in cell growth. It is administered as an injection and requires a prescription from a healthcare provider.
Is RYTELO a controlled substance?
RYTELO is not classified as a controlled substance by the DEA.
What is the generic name for RYTELO?
The generic name for RYTELO is imetelstat sodium. There are no other listed brand versions of imetelstat sodium.
What is the NDC code for RYTELO 47 mg/1?
The NDC (National Drug Code) for RYTELO 47 mg/1 is 82959-112, listed by Geron Corporation.
Other RYTELO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)